Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 5/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | GLA | P06280 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.53 |
| ▸ | CASP1 | P29466 | 1/20 | 0.53 |
| ▸ | CASP7 | P55210 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | MAOB | P27338 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 6/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | TP53 | P04637 | 2/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18222929 | 0.82 | CYP2C9 (0.47) | MAOACYP3A4ALDH1A1KDM4EGLA | |
| SCHEMBL19846946 | 0.78 | KMT2A (0.64) | MAOACYP3A4ALDH1A1KDM4EGLA | |
| SCHEMBL13348986 | 0.76 | ABCB1 (0.46) | CYP3A4ALDH1A1MAPTHPGDHSD17B10 | |
| SCHEMBL14533465 | 0.75 | CYP2C9 (0.55) | MAOACYP3A4ALDH1A1KDM4EGLA | |
| SCHEMBL311868 | 0.74 | CYP3A4 (0.68) | MAOACYP3A4ALDH1A1KDM4EMAPT | |
| SCHEMBL1568301 | 0.74 | NQO1 (0.66) | CYP3A4ALDH1A1KDM4ECYP2C9MEN1 | |
| SCHEMBL33892 | 0.73 | CYP3A4 (0.59) | MAOACYP3A4ALDH1A1KDM4EGLA | |
| SCHEMBL3456740 | 0.72 | MAOA (0.42) | MAOACYP3A4ALDH1A1KDM4EGLA | |
| SCHEMBL27978165 | 0.72 | MAOA (0.42) | MAOACYP3A4ALDH1A1KDM4EGLA | |
| SCHEMBL6854050 | 0.72 | CYP2C19 (0.40) | MAOACYP3A4ALDH1A1KDM4EGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117956977-A | Cosmetic composition | 布茨公司 | 2024-04-30 | — | — | CN | claimed |
| EP-4326892-A1 | METHOD FOR SELECTING ECOBIOLOGICAL TOPICAL COMPOSITIONS AND INGREDIENTS CAPABLE OF RESTORING OR REINFORCING THE SKIN MICROBIOTA | NAOS Institute of Life Science (FR) | 2024-02-28 | — | — | EP | claimed |
| WO-2022223928-A1 | METHOD FOR SELECTING ECOBIOLOGICAL TOPICAL COMPOSITIONS AND INGREDIENTS CAPABLE OF RESTORING OR REINFORCING THE SKIN MICROBIOTA | NAOS INSTITUTE OF LIFE SCIENCE (FR) | 2022-10-27 | — | — | WO | claimed |
| EP-3897867-A2 | COSMETIC COMPOSITIONS | Mary Kay, Inc. (US) | 2021-10-27 | — | — | EP | claimed |
| CN-106659915-B | Skin care compositions | 博姿有限公司 | 2021-05-07 | — | — | CN | claimed |
| CN-112533493-A | Enzyme molecules that mimic antioxidant activity | 比奥尼克莱公司 | 2021-03-19 | — | — | CN | claimed |
| US-20200197472-A1 | COSMETIC COMPOSITIONS | MARY KAY INC. | 2020-06-25 | — | — | US | claimed |
| WO-2020131477-A2 | COSMETIC COMPOSITIONS | MARY KAY INC. (US) | 2020-06-25 | — | — | WO | claimed |
| EP-2706981-B1 | COSMETIC COMPOSITIONS | MARY KAY INC (US) | 2019-09-04 | — | — | EP | claimed |
| EP-2788010-B1 | SKIN CARE FORMULATION | MARY KAY INC (US) | 2018-10-24 | — | — | EP | claimed |
| CN-107961211-A | Cosmetic composition | 玫琳凯有限公司 | 2018-04-27 | — | — | CN | claimed |
| US-9526689-B2 | Skin care formulation | MARY KAY INC. (US) | 2016-12-27 | — | — | US | claimed |
| US-9233062-B2 | Cosmetic compositions | MARY KAY INC. (US) | 2016-01-12 | — | — | US | claimed |
| EP-2788010-A1 | SKIN CARE FORMULATION | Mary Kay, Inc. (US) | 2014-10-15 | — | — | EP | claimed |
| EP-2706981-A2 | COSMETIC COMPOSITIONS | MARY KAY INC. (US) | 2014-03-19 | — | — | EP | claimed |
| US-20130171283-A1 | SKIN CARE FORMULATION | MARY KAY INC. (US) | 2013-07-04 | — | — | US | claimed |
| WO-2013086518-A1 | SKIN CARE FORMULATION | MARY KAY INC. (US) | 2013-06-13 | — | — | WO | claimed |
| CN-103037838-A | cosmetic composition | MARY KAY INC | 2013-04-10 | — | — | CN | claimed |
| WO-2012154949-A2 | COSMETIC COMPOSITIONS | MARY KAY INC. (US) | 2012-11-15 | — | — | WO | claimed |
| US-20120288478-A1 | COSMETIC COMPOSITIONS | MARY KAY, INC. | 2012-11-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200197472-A1 | COSMETIC COMPOSITIONS | GLA, GUSB, MMP2 | MAOA 277/4885CYP3A4 3786/4885ALDH1A1 756/4885 |
| US-20120288478-A1 | COSMETIC COMPOSITIONS | HEXA, GLA, HEXB | MAOA 302/4885CYP3A4 3362/4885ALDH1A1 566/4885 |
| US-20130171283-A1 | SKIN CARE FORMULATION | CUTA, TYR, RAD50 | MAOA 765/4885CYP3A4 1799/4885ALDH1A1 3307/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.